However, in approximately 10% of insulinomas that develop distant metastases, hypoglycemia may be refractory to conventional treatment with high intravenous glucose infusion and administration of diazoxide and SS-analogs in tumors bearing sstr2 expression [2, 44, 45]. Here, SSTR2 is linked to Hypoglycemia.